Clinical and regulatory acceptability of hierarchical composite endpoints in infectious disease clinical trials.
OBJECTIVES Hierarchical composite endpoints (HCEs) combine different clinical attributes in a single endpoint and establish a ranking of these components based on clinical importance. We studied the acceptance of HCEs in infectious disease clinical trials for clinical and regulatory decision-making. METHODS We conduc...